“…The TP53 and GRIN2B genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) according to previously described procedures with some modifications. Primer sequences used for the amplification are the same as described in previous publications [38,39]. Each 20 µl of reaction solution consisted of the following components: 10 ng genomic DNA, 1.25 U Taq polymerase (Qiagen, Chatsworth, CA, USA) in 1 × PCR buffer (100 mM Tris-HCl, pH 8.3; 500 mM KCl; 11 mM MgCl 2 , 0.1% gelatin), 1.5 mM MgCl 2 , 50 µM dNTPs and 250 nM of each primer (Sigma-Aldrich, St. Louis, MO, USA).…”